Some immunological aspects of chronic liver diseases in Egyptian children

S Abdel Fattah1, K Abdel KhaliK, L el-Shawarby

  • 1Department of Pediatrics, Ain Shams University, Cairo.

Insights

Children with chronic liver disease show impaired immune function, specifically in complement and phagocytic systems. Early assessment and infection management are crucial for better outcomes.

Area of Science:

  • Pediatric Hepatology
  • Immunology
  • Clinical Medicine

Background:

  • Chronic liver diseases in children can compromise immune function.
  • Understanding immunological disturbances is key for managing pediatric liver conditions.

Purpose of the Study:

  • To investigate the immunological status, including complement and phagocytic functions, and autoantibody profiles in Egyptian children with chronic liver diseases.
  • To correlate these immunological findings with disease severity and type.

Main Methods:

  • Evaluated 40 Egyptian children with chronic liver diseases and 20 healthy controls.
  • Assessed serum complement levels (C3, C4), neutrophil phagocytic and intracellular killing activity, and non-organ-specific autoantibodies (antinuclear, antimitochondrial, antismooth muscle).
  • Utilized techniques including single radial immunodiffusion, Candida albicans uptake assay, and indirect immunofluorescence.

Main Results:

  • Significantly increased C3 and decreased C4 levels were observed in patients, particularly those with chronic active hepatitis.
  • Neutrophil phagocytic function was impaired, more so in chronic hepatitis and cirrhosis than other forms.
  • Antismooth muscle antibodies were present in 47.5% of patients, notably in HBsAg-negative chronic active hepatitis (80%), while antinuclear and antimitochondrial antibodies were absent.

Conclusions:

  • Children with chronic liver diseases exhibit compromised complement and phagocytic system functions, potentially increasing infection susceptibility.
  • Routine immunological assessment, early infection diagnosis, and treatment are vital for managing these patients.
  • Detection of serum autoantibodies aids in the early diagnosis of autoimmune liver diseases.

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...